Literature DB >> 11860903

[Cost-effectiveness analysis of Beijing Fangshan cardiovascular prevention program in 1992 - 1997].

G Huang1, D Gu, X Wu, X Duan, X Xu, J Wu, B Xie.   

Abstract

OBJECTIVE: To determine whether a community-based cardiovascular disease (CVD) intervention program, undertaken over six years, was cost-effective.
METHODS: Based on Beijing Fangshan Cardiovascular Disease Comprehensive Prevention Program, the cost for intervention and expenditure saved from caring for CVD in the communities with intervention from 1992 to 1997 were calculated, and cost-effectiveness analysis was performed using disability-adjusted life years (DALYs) gained as an indicator of effectiveness.
RESULTS: The cost for one DALY gained reduced gradually from 1992 to 1997, with an average ratio of cost to effectiveness of four to one (4:1). It cost annually 1,586.00, 1,380.20, -2,350.80, -905.30, -1,495.60 and -1,766.70 RMB yuan for one life-year saved, from 1992 to 1997 respectively, in a gradually decreasing trend with the increase in length of intervention. After intervention for two years, ratio of cost to effectiveness has become negative since 1994, which meant a positive benefit from intervention. Sensitivity analysis showed that ratio of cost to effectiveness was little sensitive to the changes in discount rate, weight of age and increase in cost of hospitalization for stroke and coronary heart disease, which reflected its reliability.
CONCLUSION: Community-based comprehensive intervention for CVD in rural population is cost-effective.

Entities:  

Mesh:

Year:  2000        PMID: 11860903

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  2 in total

Review 1.  Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review.

Authors:  Amir Shroufi; Rajiv Chowdhury; Raghupathy Anchala; Sarah Stevens; Patricia Blanco; Tha Han; Louis Niessen; Oscar H Franco
Journal:  BMC Public Health       Date:  2013-03-28       Impact factor: 3.295

2.  Cardiovascular disease research output in WHO priority areas between 2002 and 2011.

Authors:  Laura Myers; Shanthi Mendis
Journal:  J Epidemiol Glob Health       Date:  2013-11-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.